RASSF1A methylation as a biomarker for detection of colorectal cancer and hepatocellular carcinoma

BACKGROUND: Studies have validated the potential of methylated cell-free DNA as a biomarker in various tumors, and methylated DNA in plasma may be a potential biomarker for cancer. AIM: To evaluate the diagnostic value of RASSF1A methylation in plasma for colorectal cancer (CRC) and hepatocellular c...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jian, Li, Huan, Run, Zeng-Ci, Wang, Zhen-Lei, Jiang, Tao, An, Yang, Li, Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412931/
https://www.ncbi.nlm.nih.gov/pubmed/36160746
http://dx.doi.org/10.4251/wjgo.v14.i8.1574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412931/
https://www.ncbi.nlm.nih.gov/pubmed/36160746
http://dx.doi.org/10.4251/wjgo.v14.i8.1574

Ejemplares similares